Delivery Order SPE2DB22D3004-SPE2DB25FQA52

Award Date 3/25/25
Potential Completion Date 3/26/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,812.05 firm fixed-price delivery order is for the supply of 4,560,852,418 units of 20 mg Sumatriptan nasal sprays. The contract has an ultimate completion date of May 9, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,250,728 units of 20 mg sumatriptan nasal sprays. The contract has a ceiling value of $7,496.66 and a period of performance through May 15, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $4,253.97 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,566,281,428 units of sumatriptan 6 mg/0.5 mL autoinjectors. The IDC with the DLA is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,039.72, is for the delivery of 4,568,493,394 units of Sumatriptan 20 mg nasal sprays. The contract has an ultimate completion date of June 10, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 20 mg Sumatriptan nasal sprays, with a ceiling value of $1,010.30 and a completion date of March 6, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,806,919 units of Sumatriptan 20 mg nasal sprays, with a ceiling value of $1,704.78 and a period of performance ending on April 7, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,296,703 units of Sumatriptan 20 mg nasal sprays. The contract is a firm-fixed price delivery order with a ceiling value of $1,863.38 and a period of performance through July 31, 2024. This award is not associated with a set-aside program. Amerisourcebergen has been awarded numerous federal contracts by various defense and civilian...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,503.48 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 20mg Sumatriptan nasal sprays. The contract has a completion date of September 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,057.47 firm fixed price delivery order is for the supply of Sumatriptan 25mg prescription medication. The contract has an ultimate completion date of August 7, 2024 and does not utilize a set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distributors in the United States, has been awarded various...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sumatriptan 20 mg nasal sprays, a medication used to treat migraine headaches. The contract has a ceiling value of $1,637.95 and is a firm fixed-price delivery order with a completion date of June 30, 2025. The contract is not set aside and is an open competition award....
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FQA52
    Delivery Order

This federal contract award, valued at $1,745.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sumatriptan 20 mg nasal sprays, with a performance period extending through March 26, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/24/25, 10:06 AM